Investigates the effects of Cu(II) ATCUN complexes on DNA interaction and ROS in cancer cells, indicating potential treatments.
Since the discovery of DNA cleavage and anticancer activity of the simplest Cu(II) ATCUN complex (peptide ligand: Gly-Gly-His, GGH) in 1983, systematic biological enhancements by derivatives have not been achieved....
No takes yet. Share an insight, caveat, or question.
Heinrich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: